Exploring Gene-Environment Relationships in Cardiovascular Disease

Canadian Journal of Cardiology

Volumn 29, Issue 1, 2013, Pages 37-45

  Joseph, Philip G ^a   Pare, Guillaume ^a,b,c   Anand, Sonia S ^a,b,c  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; HIGH DENSITY LIPOPROTEIN; ICOSAPENTAENOIC ACID; INSULIN; LOW DENSITY LIPOPROTEIN; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ALLELE; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; GENETIC ASSOCIATION; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LIPID METABOLISM; METABOLIC SYNDROME X; OBESITY; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

CARDIOVASCULAR DISEASES; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PROGNOSIS; RISK FACTORS;

EID: 84871411840     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2012.10.009     Document Type: Review

References (62)

1. Murray C.J., Lopez A.D. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997, 349:1269-1276.
2. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364:937-952.
3. O'Donnell M.J., Xavier D., Liu L., et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010, 376:112-123.
4. Finucane M.M., Stevens G.A., Cowan M.J., et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011, 377:557-567.
5. Danaei G., Finucane M.M., Lu Y., et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011, 378:31-40.
6. Leiter L.A., Fitchett D.H., Gilbert R.E., et al. Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group. Can J Cardiol 2011, 27:e1-e33.
7. Schunkert H., Konig I.R., Kathiresan S., et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 2011, 43:333-338.
8. A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat Genet 2011, 43:339-344. Coronary Artery Disease (C4D) Genetics Consortium.
9. O'Donnell C.J., Nabel E.G. Genomics of cardiovascular disease. N Engl J Med 2011, 365:2098-2109.
10. Do R., Xie C., Zhang X., et al. The effect of chromosome 9p21 variants on cardiovascular disease may be modified by dietary intake: evidence from a case/control and a prospective study. PLoS Med 2011, 8:e1001106.
11. Humphries S.E., Talmud P.J., Hawe E., Bolla M., Day I.N., Miller G.J. Apolipoprotein e4 and coronary heart disease in middle-aged men who smoke: a prospective study. Lancet 2001, 358:115-119.
12. Gustavsson J., Mehlig K., Leander K., et al. Interaction of apolipoprotein e genotype with smoking and physical inactivity on coronary heart disease risk in men and women. Atherosclerosis 2012, 220:486-492.
13. Florez J.C., Jablonski K.A., Bayley N., et al. TCF7L2 polymorphisms and progression to diabetes in the diabetes prevention program. N Engl J Med 2006, 355:241-250.
14. Phillips C.M., Goumidi L., Bertrais S., et al. Additive effect of polymorphisms in the IL-6, LTA, and TNF-{alpha} genes and plasma fatty acid level modulate risk for the metabolic syndrome and its components. J Clin Endocrinol Metab 2010, 95:1386-1394.
15. Kilpelainen T.O., Qi L., Brage S., et al. Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children. PLoS Med 2011, 8:e1001116.
16. Kaakinen M., Laara E., Pouta A., et al. Life-course analysis of a fat mass and obesity-associated (FTO) gene variant and body mass index in the northern finland birth cohort 1966 using structural equation modeling. Am J Epidemiol 2010, 172:653-665.
17. Corella D., Peloso G., Arnett D.K., et al. APOA2, dietary fat, and body mass index: replication of a gene-diet interaction in 3 independent populations. Arch Intern Med 2009, 169:1897-1906.
18. McPherson R. Chromosome 9p21 and coronary artery disease. N Engl J Med 2010, 362:1736-1737.
19. Harismendy O., Notani D., Song X., et al. 9p21 DNA variants associated with coronary artery disease impair interferon-gamma signalling response. Nature 2011, 470:264-268.
20. Visel A., Zhu Y., May D., et al. Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature 2010, 464:409-412.
21. Xie X., Ma Y.T., Yang Y.N., et al. Interaction between COX-2 G-765C and smoking in relation to coronary artery disease in a Chinese Uighur population. Clin Chem Lab Med 2011, 49:55-60.
22. Verghese P.B., Castellano J.M., Holtzman D.M. Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol 2011, 10:241-252.
23. Farzadfar F., Finucane M.M., Danaei G., et al. National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants. Lancet 2011, 377:578-586.
24. Teslovich T.M., Musunuru K., Smith A.V., et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010, 466:707-713.
25. Mozaffarian D., Micha R., Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 2010, 7:e1000252.
26. Glaser C., Heinrich J., Koletzko B. Role of FADS1 and FADS2 polymorphisms in polyunsaturated fatty acid metabolism. Metabolism 2010, 59:993-999.
27. Hu F.B., Manson J.E., Willett W.C. Types of dietary fat and risk of coronary heart disease: a critical review. J Am Coll Nutr 2001, 20:5-19.
28. Lu Y., Feskens E.J., Dolle M.E., et al. Dietary n-3 and n-6 polyunsaturated fatty acid intake interacts with FADS1 genetic variation to affect total and HDL-cholesterol concentrations in the Doetinchem Cohort Study. Am J Clin Nutr 2010, 92:258-265.
29. Vaughan A.M., Oram J.F. ABCG1 redistributes cell cholesterol to domains removable by high density lipoprotein but not by lipid-depleted apolipoproteins. J Biol Chem 2005, 280:30150-30157.
30. Abellan R., Mansego M.L., Martinez-Hervas S., et al. Dietary polyunsaturated fatty acids may increase plasma LDL-cholesterol and plasma cholesterol concentrations in carriers of an ABCG1 gene single nucleotide polymorphism: study in two Spanish populations. Atherosclerosis 2011, 219:900-906.
31. Smith C.E., Arnett D.K., Tsai M.Y., et al. Physical inactivity interacts with an endothelial lipase polymorphism to modulate high density lipoprotein cholesterol in the GOLDN study. Atherosclerosis 2009, 206:500-504.
32. Liu W.Y., Yin R.X., Zhang L., et al. Interactions of the LIPG 584C>T polymorphism and alcohol consumption on serum lipid levels. Alcohol 2011, 45:681-687.
33. Graf G.A., Yu L., Li W.P., et al. ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion. J Biol Chem 2003, 278:48275-48282.
34. Junyent M., Tucker K.L., Smith C.E., et al. The effects of ABCG5/G8 polymorphisms on plasma HDL cholesterol concentrations depend on smoking habit in the Boston Puerto Rican Health Study. J Lipid Res 2009, 50:565-573.
35. Knowler W.C., Barrett-Connor E., Fowler S.E., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393-403.
36. Fisher E., Boeing H., Fritsche A., Doering F., Joost H.G., Schulze M.B. Whole-grain consumption and transcription factor-7-like 2 (TCF7L2) rs7903146: gene-diet interaction in modulating type 2 diabetes risk. Br J Nutr 2009, 101:478-481.
37. Cornelis M.C., Qi L., Kraft P., Hu F.B. TCF7L2, dietary carbohydrate, and risk of type 2 diabetes in US women. Am J Clin Nutr 2009, 89:1256-1262.
38. Qi L., Cornelis M.C., Zhang C., van Dam R.M., Hu F.B. Genetic predisposition, western dietary pattern, and the risk of type 2 diabetes in men. Am J Clin Nutr 2009, 89:1453-1458.
39. Kalupahana N.S., Claycombe K.J., Moustaid-Moussa N. (n-3) Fatty acids alleviate adipose tissue inflammation and insulin resistance: mechanistic insights. Adv Nutr 2011, 2:304-316.
40. Marshall J.A., Bessesen D.H., Hamman R.F. High saturated fat and low starch and fibre are associated with hyperinsulinaemia in a non-diabetic population: the San Luis Valley diabetes study. Diabetologia 1997, 40:430-438.
41. Salmeron J., Hu F.B., Manson J.E., et al. Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr 2001, 73:1019-1026.
42. Hall A.M., Smith A.J., Bernlohr D.A. Characterization of the Acyl-CoA synthetase activity of purified murine fatty acid transport protein 1. J Biol Chem 2003, 278:43008-43013.
43. Phillips C.M., Goumidi L., Bertrais S., et al. Gene-nutrient interactions with dietary fat modulate the association between genetic variation of the ACSL1 gene and metabolic syndrome. J Lipid Res 2010, 51:1793-1800.
44. Ferguson J.F., Phillips C.M., Tierney A.C., et al. Gene-nutrient interactions in the metabolic syndrome: single nucleotide polymorphisms in ADIPOQ and ADIPOR1 interact with plasma saturated fatty acids to modulate insulin resistance. Am J Clin Nutr 2010, 91:794-801.
45. Wen W., Cho Y.S., Zheng W., et al. Meta-analysis identifies common variants associated with body mass index in East Asians. Nat Genet 2012, 44:307-311.
46. Wang K., Li W.D., Zhang C.K., et al. A genome-wide association study on obesity and obesity-related traits. PLoS One 2011, 6:e18939.
47. Lappalainen T.J., Tolppanen A.M., Kolehmainen M., et al. The common variant in the FTO gene did not modify the effect of lifestyle changes on body weight: the Finnish Diabetes Prevention Study. Obesity (Silver Spring) 2009, 17:832-836.
48. Franks P.W., Jablonski K.A., Delahanty L.M., et al. Assessing gene-treatment interactions at the FTO and INSIG2 loci on obesity-related traits in the Diabetes Prevention Program. Diabetologia 2008, 51:2214-2223.
49. Corella D., Arnett D.K., Tucker K.L., et al. A high intake of saturated fatty acids strengthens the association between the fat mass and obesity-associated gene and BMI. J Nutr 2011, 141:2219-2225.
50. Ordovas J.M., Robertson R., Cleirigh E.N. Gene-gene and gene-environment interactions defining lipid-related traits. Curr Opin Lipidol 2011, 22:129-136.
51. Corella D., Tai E.S., Sorli J.V., et al. Association between the APOA2 promoter polymorphism and body weight in Mediterranean and Asian populations: replication of a gene-saturated fat interaction. Int J Obes (Lond) 2011, 35:666-675.
52. Razquin C., Martinez J.A., Martinez-Gonzalez M.A., Fernandez-Crehuet J., Santos J.M., Marti A. A Mediterranean diet rich in virgin olive oil may reverse the effects of the -174G/C IL6 gene variant on 3-year body weight change. Mol Nutr Food Res 2010, 54(suppl 1):S75-S82.
53. Jourdan C., Kloiber S., Nieters A., et al. Gene-PUFA interactions and obesity risk. Br J Nutr 2011, 106:1263-1272.
54. Danaei G., Finucane M.M., Lin J.K., et al. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants. Lancet 2011, 377:568-577.
55. Pan X.Q., Zhang Y.H., Liu Y.Y., et al. Interaction between the C(-344)T polymorphism of CYP11B2 and alcohol consumption on the risk of essential hypertension in a Chinese Mongolian population. Eur J Epidemiol 2010, 25:813-821.
56. Menni C., Bagnardi V., Padmanabhan S., et al. Evaluation of how gene-job strain interaction affects blood pressure in the PAMELA study. Psychosom Med 2011, 73:304-309.
57. Tobe S.W., Baker B., Hunter K., et al. The impact of endothelin-1 genetic analysis and job strain on ambulatory blood pressure. J Psychosom Res 2011, 71:97-101.
58. Nawaz S.K., Hasnain S. Effect of ACE polymorphisms on the association between noise and hypertension in a Pakistani population. J Renin Angiotensin Aldosterone Syst 2011, 12:516-520.
59. Shirodkar A.V., Marsden P.A. Epigenetics in cardiovascular disease. Curr Opin Cardiol 2011, 26:209-215.
60. Anand S.S., Xie C., Pare G., et al. Genetic variants associated with myocardial infarction risk factors in over 8000 individuals from five ethnic groups: the INTERHEART Genetics Study. Circ Cardiovasc Genet 2009, 2:16-25.
61. Serre D., Montpetit A., Pare G., et al. Correction of population stratification in large multi-ethnic association studies. PLoS One 2008, 3:e1382.
62. Marteau T.M., French D.P., Griffin S.J., et al. Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours. Cochrane Database Syst Rev 2010, CD007275.